Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection. - Wikidata - awgldk - TriplyDB

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

http://www.wikidata.org/entity/Q37593797

about

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

http://www.wikidata.org/entity/Q37593797

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

@en

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

@nl

type

label

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

@en

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

@nl

prefLabel

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

@en

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

@nl

P1433

Q37593797-10DFAD43-2D73-43AF-904C-CB5102ECC5D7

P1476

Q37593797-BA63BBFE-DAAB-452E-AE9E-C8CF1ADC0721

P2093

Q37593797-0CE8E7A7-702B-4B2D-A428-C036CF28E1CC

Q37593797-289298A9-90E4-4F72-A0AE-001BC3BEFBB8

Q37593797-89E9A865-23BB-453C-BE36-DC2059219CF7

P2860

Q37593797-3C1B8491-4A33-485C-B08B-37F989FCE16B

Q37593797-69F5FE6F-9F03-4BD6-A2A8-9FDE0E3BBD04

Q37593797-6F814345-9699-42C0-B856-AC21F9D093A5

Q37593797-9C8D1076-22F2-4351-A7D8-9E5B44599AF0

Q37593797-9FC06CA1-7432-470A-8A65-92244CF0216C

Q37593797-A0AEEE56-9F79-43D8-89A3-7B53ECFD5167

Q37593797-ABE39EC6-2488-4943-94C7-F1F77595DFB9

Q37593797-B118CAB7-596B-4F7C-A1E4-E26CD551E4B1

Q37593797-C27226AC-35EB-43E6-8A6B-2AA87498AFD1

Q37593797-CE8F3DE3-42E2-48BE-A0C2-B11870176F20

P304

Q37593797-C66879BF-0BD4-44B8-8355-322A03558F31

P31

Q37593797-E28C0785-1B94-4C8F-ABB7-B21328711099

P356

Q37593797-F3A808C7-1A4A-465C-A593-5C6E2D69EC17

P407

Q37593797-DA1EE638-1BAB-4CA7-9E9F-2FBE42802B22

P433

Q37593797-907FEDEB-697D-4231-ADC8-2E758747E0F8

P478

Q37593797-611E0DEE-939D-4703-891C-3E3E1A380F3F

P577

Q37593797-CBC7B1AB-27A6-495C-AC8F-BC723417C488

P698

Q37593797-1136CA74-0DD4-4183-9155-7CE3524AE76A

P356

P1433

Annals of Pharmacotherapy

P1476

Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.

@en

P2093

Linda M Spooner

http://www.w3.org/2001/XMLSchema#string

Monica M Gaffney

http://www.w3.org/2001/XMLSchema#string

Paul P Belliveau

http://www.w3.org/2001/XMLSchema#string

P2860

Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutations

Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients

In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection.

Apricitabine: a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor for the treatment of nucleoside-resistant HIV infection.

Differential maintenance of the M184V substitution in the reverse transcriptase of human immunodeficiency virus type 1 by various nucleoside antiretroviral agents in tissue culture.

In vitro interactions between apricitabine and other deoxycytidine analogues

Effect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers.

In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs.

Pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers treated with trimethoprim-sulphamethoxazole.

Multiple-dose pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in patients with HIV-1 infection.

P304

1676-1683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1M160

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19737995

http://www.w3.org/2001/XMLSchema#string